Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 14 studies | 28% ± 12% | |
macrophage | 14 studies | 26% ± 12% | |
monocyte | 7 studies | 21% ± 9% | |
myeloid cell | 7 studies | 24% ± 8% | |
adipocyte | 7 studies | 32% ± 12% | |
astrocyte | 6 studies | 35% ± 10% | |
Mueller cell | 6 studies | 52% ± 18% | |
neutrophil | 5 studies | 35% ± 19% | |
microglial cell | 5 studies | 25% ± 6% | |
platelet | 5 studies | 23% ± 7% | |
oligodendrocyte precursor cell | 5 studies | 29% ± 12% | |
non-classical monocyte | 4 studies | 28% ± 8% | |
epithelial cell | 4 studies | 36% ± 10% | |
basal cell | 4 studies | 30% ± 12% | |
hematopoietic precursor cell | 3 studies | 33% ± 20% | |
megakaryocyte | 3 studies | 24% ± 7% | |
abnormal cell | 3 studies | 29% ± 11% | |
hepatocyte | 3 studies | 40% ± 17% | |
hematopoietic stem cell | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 6163.58 | 226 / 226 | 95% | 71.30 | 386 / 406 |
uterus | 100% | 3156.69 | 170 / 170 | 93% | 84.61 | 426 / 459 |
breast | 100% | 4813.31 | 459 / 459 | 86% | 47.51 | 965 / 1118 |
skin | 100% | 3943.66 | 1804 / 1809 | 86% | 165.30 | 407 / 472 |
lung | 100% | 3593.53 | 576 / 578 | 85% | 47.86 | 979 / 1155 |
ovary | 100% | 2314.34 | 180 / 180 | 78% | 23.26 | 336 / 430 |
bladder | 90% | 3962.38 | 19 / 21 | 88% | 71.90 | 441 / 504 |
esophagus | 89% | 3241.03 | 1279 / 1445 | 73% | 53.25 | 134 / 183 |
intestine | 91% | 2045.40 | 877 / 966 | 65% | 23.73 | 340 / 527 |
prostate | 98% | 1786.72 | 240 / 245 | 51% | 12.45 | 258 / 502 |
kidney | 65% | 1032.96 | 58 / 89 | 83% | 37.67 | 750 / 901 |
thymus | 94% | 1433.93 | 613 / 653 | 47% | 9.66 | 285 / 605 |
adrenal gland | 97% | 2693.23 | 249 / 258 | 9% | 2.88 | 20 / 230 |
adipose | 100% | 7590.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 6411.80 | 239 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 284.57 | 79 / 80 |
blood vessel | 98% | 2255.30 | 1307 / 1335 | 0% | 0 | 0 / 0 |
stomach | 52% | 871.52 | 185 / 359 | 46% | 14.27 | 131 / 286 |
pancreas | 11% | 124.15 | 36 / 328 | 83% | 32.81 | 148 / 178 |
brain | 28% | 412.07 | 729 / 2642 | 62% | 25.70 | 435 / 705 |
tonsil | 0% | 0 | 0 / 0 | 87% | 65.25 | 39 / 45 |
peripheral blood | 82% | 29279.02 | 759 / 929 | 0% | 0 | 0 / 0 |
heart | 50% | 796.17 | 429 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 4.69 | 6 / 29 |
muscle | 10% | 124.95 | 83 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0009617 | Biological process | response to bacterium |
GO_0006015 | Biological process | 5-phosphoribose 1-diphosphate biosynthetic process |
GO_0005980 | Biological process | glycogen catabolic process |
GO_0070266 | Biological process | necroptotic process |
GO_0042593 | Biological process | glucose homeostasis |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0008184 | Molecular function | glycogen phosphorylase activity |
GO_0019842 | Molecular function | vitamin binding |
GO_0030170 | Molecular function | pyridoxal phosphate binding |
GO_0102250 | Molecular function | linear malto-oligosaccharide phosphorylase activity |
GO_0102499 | Molecular function | SHG alpha-glucan phosphorylase activity |
GO_0016208 | Molecular function | AMP binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0032052 | Molecular function | bile acid binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005536 | Molecular function | D-glucose binding |
GO_0002060 | Molecular function | purine nucleobase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PYGL |
Protein name | Glycogen phosphorylase, liver form (EC 2.4.1.1) Alpha-1,4 glucan phosphorylase (EC 2.4.1.1) |
Synonyms | |
Description | FUNCTION: Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis. . FUNCTION: Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis. . FUNCTION: Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis. . |
Accessions | ENST00000544180.6 [P06737-2] ENST00000532462.5 Q6P1L4 P06737 ENST00000216392.8 [P06737-1] E9PK47 |